ARB-002/Colistimethate sodium
N/A
Report date: 2023/01/01 09:47:59
Base Information
Drug NameARB-002/Colistimethate sodium
Drug Alias Name +[6]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes ARB-002Colistimethate sodium
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesHelperby Therapeutics Ltd
China Registration ClassN/A
Develop Information
Active CompaniesHelperby Therapeutics Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A